Bausch + Lomb (BLCO) | Stock Overview & Key Data
Bausch + Lomb Performance Comparison
Stock Range
Today's Range
Low: $14.61
High: $14.98
on October 7, 2025
52 Week Range
Low: $10.45
High: $21.69
on April 30, 2025
on October 14, 2024
All-Time High: $21.95 on June 26, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$5.4B
EPS
-0.78
P/E Ratio (TTM)
-16.89
Forward P/E
12.77
P/B Ratio
0.84
PEG Ratio
0.29
Div. Yield
N/A
ROE
-4.02%
Beta
0.631
Debt to Equity
76.20
Financial Highlights
Profitability
Gross Margin
58.92%
Operating Margin
0.86%
Profit Margin
-5.58%
Returns and Earnings
Return on Assets (TTM)
0.47%
Return on Equity (TTM)
-4.02%
EBITDA
$544.0M
Net Income (TTM)
$-273.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$13.88
Quarterly Revenue Growth (YoY)
5.10%
Quarterly Earnings Growth (YoY)
5.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Bausch + Lomb BLCO | 5.39B Mid-cap | -0.47% | -4.06% | 7.82% | 25.44% | -17.28% | -23.52% | 1.36% | 192.53% |
| Intuitive Surgical ISRG | 163.30B Large-cap | 2.38% | -4.32% | -15.90% | -3.00% | -14.19% | -7.24% | 145.65% | 79.24% |
| Becton, Dickinson BDX | 55.67B Large-cap | 4.34% | 0.21% | 11.01% | -6.38% | -15.23% | -18.82% | -14.56% | -16.96% |
| Avantor AVTR | 9.74B Mid-cap | 19.00% | 7.31% | 4.29% | -7.49% | -33.54% | -43.07% | -28.04% | -42.40% |
| Align Technology ALGN | 9.65B Mid-cap | 4.06% | -3.92% | -32.16% | -14.25% | -36.93% | -40.78% | -34.78% | -60.92% |
| AptarGroup ATR | 8.78B Mid-cap | -0.29% | -4.64% | -18.07% | -2.06% | -14.45% | -18.37% | 38.70% | 13.35% |
Ownership & Short Interest
Insider Ownership
88.06%
Institutional Ownership
11.27%
Shares Short
3M
Short Ratio
6.33
Short % of Shares Outstanding
7.55%
Average 10-Day Volume
575K
Average 90-Day Volume
535K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BLCO's 52-week high and low?
- In the last 52 weeks, Bausch + Lomb reached a high of $21.69 (on October 14, 2024) and a low of $10.45 (on April 30, 2025).
- What is the market cap and P/E ratio for BLCO?
- Curious about Bausch + Lomb's size and valuation? Its market capitalization stands at 5.39B. When it comes to valuation, the P/E ratio (trailing twelve months) is -16.89, and the forward P/E (looking ahead) is 12.77.
- Does BLCO pay dividends? If so, what's the yield?
- As for dividends, Bausch + Lomb isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Bausch + Lomb's main competitors or similar companies to consider before investing?
When looking at Bausch + Lomb, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG163.30B Healthcare Medical Instruments & Supplies -7.24% 145.65% Becton, Dickinson
BDX55.67B Healthcare Medical Instruments & Supplies -18.82% -14.56% Avantor
AVTR9.74B Healthcare Medical Instruments & Supplies -43.07% -28.04% Align Technology
ALGN9.65B Healthcare Medical Instruments & Supplies -40.78% -34.78% AptarGroup
ATR8.78B Healthcare Medical Instruments & Supplies -18.37% 38.70% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bausch + Lomb Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Bausch + Lomb's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -4.02%, the Debt to Equity ratio from the most recent quarter is 76.20, and its Gross Profit Margin stands at 58.92%.
- What is the recent revenue and earnings growth for BLCO?
- Looking at Bausch + Lomb's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.10%, and quarterly earnings saw a YoY growth of 5.10%.
- How much of BLCO stock is held by insiders and institutions?
- Wondering who owns Bausch + Lomb stock? Company insiders (like executives and directors) hold about 88.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 11.27%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.